CMV infection in the donor and increased kidney graft loss: Impact of full HLA-I mismatch and posttransplantation CD8+ cell reduction

American Journal of Transplantation

Volumn 13, Issue 8, 2013, Pages 2119-2129

  Gatault, P ^a,b   Halimi, J M ^a,b   Forconi, C ^a   Thibault, G ^b,c   Barbet, C ^b   Merieau E ^b   Gaudy Graffin, C ^b,d   Marliere J F ^b   Goudeau, A ^b,d   Bruyere F ^b   Lebranchu, Y ^a,b   Buchler M ^a,b   Baron, C ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c CNRS   (France)

^d INSERM   (France)

Author keywords

Allocation; cytomegalovirus; HLA matching; kidney transplantation; T cell

Indexed keywords

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ALLOCATION; CYTOMEGALOVIRUS; HLA MATCHING; KIDNEY TRANSPLANTATION; T CELL;

ADULT; ANTIGENS, CD8; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS;

EID: 84881367393     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12298     Document Type: Article

References (42)

1. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ., Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43: 1143-1151.
2. Davison AJ, Dolan A, Akter P, et al. The human cytomegalovirus genome revisited: Comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 2003; 84: 17-28.
3. Soderberg-Naucler C, Fish KN, Nelson JA., Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119-126.
4. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH., Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005; 102: 4140-4145.
5. Soderberg-Naucler C., HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008; 41: 218-223.
6. Simon CO, Holtappels R, Tervo HM, et al. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 2006; 80: 10436-10456.
7. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor. N Engl J Med 1995; 333: 1038-1044.
8. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685.
9. Quigley M, Pereyra F, Nilsson B, et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 2010; 16: 1147-1151.
10. Ouyang Q, Wagner WM, Voehringer D, et al. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol 2003; 38: 911-920.
11. Ouyang Q, Wagner WM, Wikby A, et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003; 23: 247-257.
12. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G., Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 2004; 39: 607-613.
13. Mattes FM, Vargas A, Kopycinski J, et al. Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant 2008; 8: 990-999.
14. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006; 176: 2645-2653.
15. Antoine P, Olislagers V, Huygens A, et al. Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. J Immunol 2012; 189: 2665-2672.
16. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, et al. Cytomegalovirus- specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175: 8218-8225.
17. Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11: 187-195.
18. Streblow DN, Orloff SL, Nelson JA., Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007; 19: 577-582.
19. Freeman RB, Jr., The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009; 9: 2453-2458.
20. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE., Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561-3566.
21. Snyder LD, Finlen-Copeland CA, Turbyfill WJ, Howell D, Willner DA, Palmer SM., Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010; 181: 1391-1396.
22. Paraskeva M, Bailey M, Levvey BJ, et al. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome. Am J Transplant 2011; 11: 2190-2196.
23. Johnson RJ, Clatworthy MR, Birch R, Hammad A, Bradley JA., CMV mismatch does not affect patient and graft survival in UK renal transplant recipients. Transplantation 2009; 88: 77-82.
24. Schnitzler MA, Lowell JA, Hardinger KL, Boxerman SB, Bailey TC, Brennan DC., The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant 2003; 3: 445-451.
25. van Ree RM, de Vries AP, Zelle DM, et al. Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients. Med Sci Monit 2011; 17: 609-617.
26. Kyllonen L, Kahu J, Salmela K., Kidney transplantation from 1119 deceased donors in Finland, 1991 to 2003: Impact of donor factors. Transplant Proc 2005; 37: 3248-3252.
27. Smith JM, Corey L, Bittner R, et al. Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol 2010; 21: 1579-1586.
28. Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V., Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation 2009; 87: 436-444.
29. Helantera I, Koskinen P, Finne P, et al. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 2006; 19: 893-900.
30. Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ., Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 1999; 68: 1879-1883.
31. Giral M, Nguyen JM, Daguin P, et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. J Am Soc Nephrol 2001; 12: 1758-1763.
32. Erdbruegger U, Scheffner I, Mengel M, et al. Impact of CMV infection on acute rejection and long-term renal allograft function: A systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transplant 2011; 27: 435-443.
33. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW., IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest 2001; 107: 15-22.
34. Roland M, Gatault P, Al-Najjar A, et al. Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2008; 8: 1719-1728.
35. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D., A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470.
36. Schwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A., A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
37. Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004; 173: 7481-7489.
38. Liapis H, Storch GA, Hill DA, Rueda J, Brennan DC., CMV infection of the renal allograft is much more common than the pathology indicates: A retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR. Nephrol Dial Transplant 2003; 18: 397-402.
39. Hughes D, Hafferty J, Fulton L, et al. Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients. J Clin Virol 2008; 41: 92-95.
40. Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004; 66: 329-337.
41. Virgin HW, Wherry EJ, Ahmed R., Redefining chronic viral infection. Cell 2009; 138: 30-50.
42. Wherry EJ., T cell exhaustion. Nat Immunol 2011; 12: 492-499.